Tuesday, December 07, 2010 2:33:31 AM
due to cash shortages, which severely compromised the ability of the Company to build or sell any new BFA Systems.
Also, new independent sales representatives became disinterested when they were unable to receive products in a reasonable
time period. With adequate financial support, the Company anticipates continuing the upward trend in Blood Flow
Analyzer™ sales through additional efforts by the Company to gain widespread support for the Blood Flow Analyzer™
through increased clinical awareness, produce development and improved marketing plans.
First sentence caught my attention. Looks like they don't have the money to order parts for Blood Flow Analyzer.
FEATURED CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • Oct 8, 2024 8:00 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM